Evidence map›Paper›PMID 40213123›Full record

ArticleInnovations in clinical neuroscience

Azithromycin-induced Adolescent Manic Episode with Psychotic Features: A Case Report.

Amro H Mohammad, Marie-Pier Lecours, Emmanuel Adams-Gelinas, Arshia Kakkar, Anthi Stefatos

Abstract readCase Reports
In one paragraph

Article in Innovations in clinical neuroscience. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amro H MohammadDr. Mohammad, Mr. Adams-Gelinas, and Dr. Kakkar are with the Faculty of Medicine and Health Sciences at McGill University in Montreal, Quebec, Canada.
Marie-Pier LecoursDr. Lecours is with Hôpital Pierre-Boucher in Longueuil, Quebec, Canada.
Emmanuel Adams-GelinasDr. Mohammad, Mr. Adams-Gelinas, and Dr. Kakkar are with the Faculty of Medicine and Health Sciences at McGill University in Montreal, Quebec, Canada.
Arshia KakkarDr. Mohammad, Mr. Adams-Gelinas, and Dr. Kakkar are with the Faculty of Medicine and Health Sciences at McGill University in Montreal, Quebec, Canada.
Anthi StefatosDr. Stefatos is with the Department of Psychiatry at McGill University in Montreal, Quebec, and the Department of Psychiatry, Integrated University Health and Social Services Center of the West Island of Montreal (CIUSSS ODIM) in Pointe-Claire, Quebec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Premarketing clinical trials of azithromycin (AZT) computed a 0.8-percent incidence rate of neurological symptoms, such as headaches and vertigo. Postmarket surveillance reported on psychiatric reactions to AZT that included aggression, agitation, anxiety, delirium, and hallucinations. Nonetheless, these observations do not provide further insight on patient characteristics, disease course, and medical intervention. Methods: We report the case of an 18-year-old male patient with no prior medical or psychiatric history who developed profound religious delusions and unusual behavior hours after taking a one-time AZT dose of 1,000mg for a confirmed sexually transmitted Results: The patient presentation and clinical history satisfied criteria for a manic episode with psychotic features lasting for at least one week. As per Conclusion: We report, to our knowledge for the first time, that AZT monotherapy might induce a manic episode with psychotic features in adolescent patients with no psychiatric medical history.

Indexed as

Azithromycinmacrolidemanic episode

Identifiers

PMID40213123
PMCPMC11980907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.